Clinical Trial Update: Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of eltrombopag plus tacrolimus in Chinese patients with refractory or relapsed aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemia, Drug Effect | Phase 2 | Status: COMPLETED